US Stock MarketDetailed Quotes

RENB Renovaro

Watchlist
  • 1.750
  • +0.250+16.67%
Close Jun 28 16:00 ET
  • 1.690
  • -0.060-3.43%
Post 19:30 ET
269.37MMarket Cap-2187P/E (TTM)

About Renovaro Company

Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Company Profile

SymbolRENB
Company NameRenovaro
Listing DateDec 10, 2018
Founded2011
CEODr. Mark R. Dybul, M.D.
MarketNASDAQ
Employees12
Securities TypeOrdinary Shares
Fiscal Year Ends06-30
Address1927 Paseo Rancho Castillo
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90032-2012
Phone1-305-918-1980
Websitehttp://www.enochianbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Mark R. Dybul, M.D.
  • Executive Vice Chairman of the Board and Chief Executive Officer
  • 10.75M
  • Simon Tarsh
  • Interim Chief Financial Officer
  • --
  • Luisa Puche
  • Chief Financial Officer and Principal Accounting Officer
  • 789.34K
  • Francois Binette
  • Managing Director and President
  • --
  • Rene Sindlev
  • Chairman of the Board
  • 153.40K
  • Avram Miller
  • Director
  • --
  • Karen Brink
  • Director
  • --
  • Leni M.T. Boeren
  • Independent Director
  • --
  • Jayne McNicol
  • Independent Director
  • 128.23K
  • Gregg H. Alton, J.D.
  • Independent Director
  • 130.49K
  • James Sapirstein
  • Independent Director
  • 129.57K
  • Dr. Carol L. Brosgart, M.D.
  • Independent Director
  • 122.93K
  • Ruud Hendriks
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-5.75%